Related Experiment Video
Updated: Jul 2, 2026
11:59
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Beta-thalassemia mutations in western India.
J J Sheth1, F J Sheth, Pooja Pandya
1FRIGE Institute of Human Genetics, FRIGE House, Satellite, Ahmedabad, India. jshethad1@sancharnet.in
Indian Journal of Pediatrics
|September 2, 2008
Summary
This study identified high-risk communities for beta thalassemia in Gujarat, with IVS 1-5 (G-->C) being the most common mutation. Molecular evaluation is recommended for families from these at-risk ethnic groups.
Area of Science:
- Genetics
- Molecular Biology
- Public Health
Background:
- Beta-thalassemia is a significant genetic disorder.
- Understanding mutation prevalence is crucial for genetic screening.
- Gujarat's diverse population presents unique genetic landscapes.
Purpose of the Study:
- To investigate common beta-thalassemia mutations in Gujarat.
- To identify high-risk communities for this genetic disorder.
- To determine the most prevalent mutation within these communities.
Main Methods:
- Mutation screening was performed using Amplification Refractory Mutation System-Polymerase Chain Reaction (ARMS-PCR).
- The study focused on children diagnosed with beta-thalassemia.
Main Results:
- Population screening identified Sindhis, Lohana, Rajputs, and SC/ST/OBC communities as high-risk groups.
- The IVS 1-5 (G-->C) mutation was the most frequently observed.
- 619 bp deletions were also a common mutation identified in Gujarat.
Conclusions:
- Molecular evaluation for beta-thalassemia is advised for families of high-risk ethnic origins.
- Targeted screening can improve early detection and management of beta-thalassemia.
Related Concept Videos
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
02:18Alternative RNA Splicing
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:49Multiple Allele Traits
The Concept of Multiple Allelism
01:30Point and Frameshift Mutations
Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...